Spire Wealth Management Actinium Pharmaceuticals, Inc. Transaction History

Spire Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	SELL	$4.57 - $6.4 $8,226 - $11,520	-1,800 Closed	0 $0
Q4 2021 Jan 14, 2022	BUY	$6.01 - $8.8 $10,818 - $15,840	1,800 New	1,800 $11,000
Q2 2021 Jul 26, 2021	SELL	$7.01 - $8.63 $12,618 - $15,534	-1,800 Closed	0 $0
Q1 2021 May 21, 2021	BUY	$7.62 - $9.79 $13,716 - $17,622	1,800 New	1,800 $15,000

8.32M

65.2K

21.7K

Ticker ATNM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,184,700
Market Cap $41.6M
Description
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.